This Viewpoint argues for earlier follow-up of low-risk but measurable lesions according to the Ovarian-Adnexal Reporting and Data System.
No takes yet. Share an insight, caveat, or question.
Ohad D. Rotenberg (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: